Key result
Atrial fibrillation affects 1% to 1.5% of the developed world population and carries a 5-fold increased risk of stroke, driving the development of novel pharmacological and mechanical therapies.
Population
Patients with atrial fibrillation
Design
Review
Authors
Loading...
Highlights the ongoing clinical burden of AF-related stroke; leaves open the comparative efficacy.
This review summarizes the epidemiology, mechanisms, and emerging antithrombotic and mechanical stroke prevention strategies for atrial fibrillation.
Savelieva et al. (2008) conducted a review in Atrial Fibrillation. Atrial fibrillation affects 1% to 1.5% of the developed world population and carries a 5-fold increased risk of stroke, driving the development of novel pharmacological and mechanical therapies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: